Database : MEDLINE
Search on : pityriasis [Words]
References found : 3184 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 319 go to page                         

  1 / 3184 MEDLINE  
              next record last record
select
to print
Photocopy
Full text

[PMID]: 29520857
[Au] Autor:Alame MM; Chamsy DJ; Zaraket H
[Ad] Address:School of Pharmacy, Lebanese International University, Beirut, Lebanon.
[Ti] Title:Pityriasis rosea-like eruption associated with ondansetron use in pregnancy.
[So] Source:Br J Clin Pharmacol;, 2018 Mar 09.
[Is] ISSN:1365-2125
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:A 30-year-old pregnant female presented with a 2-week history of pityriasis rosea-like eruption. The rash started 2 days after the patient had started taking ondansetron 8 mg for alleviation of moderate-to-severe nausea and vomiting of pregnancy. Physical examination revealed erythematous papulosquamous lesions characterized by annular scaly margins and a dusky centre over the arms, chest, abdomen, lower back and legs. The rash did not involve the palms, sole or mucous membranes, and no lesions were observed on the lymph nodes. Ondansetron was discontinued. The rash ceased to spread and started to disappear within 2 weeks with full resolution noted after 1 month. Analysis of the case using the Naranjo adverse drug reaction probability scale indicated that ondansetron was the probable cause of the pityriasis rosea-like eruption. This is the first case report of pityriasis rosea related to ondansetron therapy.
[Pt] Publication type:CASE REPORTS
[Em] Entry month:1803
[Cu] Class update date: 180309
[Lr] Last revision date:180309
[St] Status:Publisher
[do] DOI:10.1111/bcp.13560

  2 / 3184 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29518460
[Au] Autor:Maloney NJ; Hisaw LD; Worswick S
[Ad] Address:David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
[Ti] Title:Type I pityriasis rubra pilaris treated with tumor necrosis factor inhibitors, ustekinumab, or secukinumab: a systematic review.
[So] Source:J Am Acad Dermatol;, 2018 Mar 05.
[Is] ISSN:1097-6787
[Cp] Country of publication:United States
[La] Language:eng
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1803
[Cu] Class update date: 180308
[Lr] Last revision date:180308
[St] Status:Publisher

  3 / 3184 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29400288
[Au] Autor:Pellonnet L; Beltzung F; Franck F; Rouanet J; D'incan M
[Ad] Address:Department of Dermatology.
[Ti] Title:A case of severe pityriasis rubra pilaris with a dramatic response to apremilast.
[So] Source:Eur J Dermatol;28(1):128-129, 2018 Feb 01.
[Is] ISSN:1952-4013
[Cp] Country of publication:France
[La] Language:eng
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180309
[Lr] Last revision date:180309
[St] Status:In-Data-Review
[do] DOI:10.1684/ejd.2017.3187

  4 / 3184 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29512184
[Au] Autor:Itoh Y; Asahina A; Kanbe M; Ito K; Nakagawa H
[Ad] Address:Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.
[Ti] Title:Case of pityriasis rubra pilaris with focal acantholytic dyskeratosis.
[So] Source:J Dermatol;, 2018 Mar 06.
[Is] ISSN:1346-8138
[Cp] Country of publication:England
[La] Language:eng
[Pt] Publication type:LETTER
[Em] Entry month:1803
[Cu] Class update date: 180307
[Lr] Last revision date:180307
[St] Status:Publisher
[do] DOI:10.1111/1346-8138.14286

  5 / 3184 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 29292942
[Au] Autor:Lysell J
[Ad] Address:Karolinska Universitetssjukhuset Hudkliniken - Stockholm, Sweden Karolinska Universitetssjukhuset Hudkliniken - Stockholm, Sweden.
[Ti] Title:Psoriasis med debut i barndom och ungdom - Risken för samsjuklighet och påverkan på livskvaliteten måste uppmärksammas.
[So] Source:Lakartidningen;114, 2017 Nov 21.
[Is] ISSN:1652-7518
[Cp] Country of publication:Sweden
[La] Language:swe
[Ab] Abstract:Psoriasis in childhood and adolescence Psoriasis is a common inflammatory disease affecting 2-3% of the worldwide population. Onset in childhood and adolescence is not uncommon and around 30% of patients report onset before 20 years of age. Childhood psoriasis has been shown to differ in clinical presentation and in underlying genetics compared to adult psoriasis patients. To diagnose psoriasis in children with mild skin involvement may be difficult and the correct diagnosis is often delayed in children compared to adult psoriasis patients. Differential diagnoses include eczema, tinea and pityriasis rubra pilaris (PRP). Topical therapy is often effective but UV-therapy and systemic therapy is sometimes indicated.
[Mh] MeSH terms primary: Psoriasis
[Mh] MeSH terms secundary: Adolescent
Age of Onset
Child
Child, Preschool
Comorbidity
Humans
Infant
Psoriasis/epidemiology
Psoriasis/genetics
Psoriasis/pathology
Psoriasis/therapy
Quality of Life
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1803
[Cu] Class update date: 180306
[Lr] Last revision date:180306
[Js] Journal subset:IM
[Da] Date of entry for processing:180103
[St] Status:MEDLINE

  6 / 3184 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29505089
[Au] Autor:Pedrosa AF; Lisboa C; Faria-Ramos I; Silva RM; Miranda IM; Rodrigues AG
[Ad] Address:Division of Microbiology, Department of Pathology, Faculty of Medicine, University of Porto, Portugal.
[Ti] Title:Malassezia species retrieved from skin with pityriasis versicolor, seborrheic dermatitis and skin free of lesions: a comparison of two sampling methods.
[So] Source:Br J Dermatol;, 2018 Mar 05.
[Is] ISSN:1365-2133
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:Malassezia are involved in the pathogenesis of different skin diseases including pityriasis versicolor (PV) and seborrheic dermatitis (SD), but these yeasts are also important inhabitants of the skin microbiome. Culture is not performed routinely, although it may be of value in doubtful cases to support the diagnosis; culture is crucial for identification tools such as matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Culture is also critical to assess the number of organisms and viability and, eventually, to perform antifungal susceptibility tests. This article is protected by copyright. All rights reserved.
[Pt] Publication type:LETTER
[Em] Entry month:1803
[Cu] Class update date: 180305
[Lr] Last revision date:180305
[St] Status:Publisher
[do] DOI:10.1111/bjd.16521

  7 / 3184 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29477734
[Au] Autor:Craiglow BG; Boyden LM; Hu R; Virtanen M; Su J; Rodriguez G; McCarthy C; Luna P; Larralde M; Humphrey S; Holland KE; Hogeling M; Hidalgo-Matlock B; Ferrari B; Fernandez-Faith E; Drolet B; Cordoro KM; Bowcock AM; Antaya RJ; Ashack K; Ashack RJ; Lifton RP; Milstone LM; Paller AS; Choate KA
[Ad] Address:Department of Dermatology, Yale University School of Medicine, New Haven, CT.
[Ti] Title:A Spectrum Including Features of Psoriasis and Pityriasis Rubra Pilaris.
[So] Source:J Am Acad Dermatol;, 2018 Feb 22.
[Is] ISSN:1097-6787
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:BACKGROUND: Heterozygous mutations in CARD14 have been shown to be associated with psoriasis and familial pityriasis rubra pilaris (PRP). Many patients with CARD14 mutations display features of both disorders, which can result in diagnostic uncertainty. In addition, these eruptions are often recalcitrant to conventional psoriasis therapies such as methotrexate, oral retinoids and TNF-α inhibitors. OBJECTIVE: We sought to describe the clinical characteristics, family history, and response to therapy in subjects with papulosquamous eruptions due to mutations in CARD14. METHODS: Subjects were referred for genetic testing as part of a registry of patients with inherited disorders of keratinization. DNA was isolated from blood or saliva, and multiplex targeted next generation sequencing or whole exome sequencing was performed. Clinical histories of subjects with CARD14 mutations were reviewed. RESULTS: We identified 15 kindreds with CARD14-associated papulosquamous eruption (CAPE). Characteristic features of CAPE include early age of onset, prominent involvement of the cheeks, chin and ears, family history of psoriasis or PRP, minimal response to conventional topical and systemic psoriasis therapies, and improvement with ustekinumab. LIMITATIONS: Relatively small sample size. CONCLUSIONS: Many subjects with CARD14 mutations display characteristics of both psoriasis and PRP. We propose the term CARD14-associated papulosquamous eruption (CAPE) to describe this spectrum of disease. Patients with clinical features suggestive of CAPE should undergo CARD14 sequencing and may benefit from treatment with ustekinumab.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180225
[Lr] Last revision date:180225
[St] Status:Publisher

  8 / 3184 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 29469755
[Au] Autor:Ciccarese G; Drago F
[Ad] Address:Department of Dermatology, IRCCS AOU San Martino, Genoa, Italy. giuliaciccarese@libero.it.
[Ti] Title:Atypical presentations of pityriasis rosea: a reply.
[So] Source:Dermatol Online J;23(8), 2017 Aug 15.
[Is] ISSN:1087-2108
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Pityriasis rosea (PR) may have atypical presentations as regards morphology and distribution of the lesions. Recently, several forms of PR considered atypical for the course of the disease have been described. Differently from the typical PR that resolves within 2-12 weeks, relapsing and persistent PR forms (lasting longer than 12 weeks) have been described in adults and children. Lesions of the oral mucosa in PR may be more common than as reported in the literature. Formerly, the occurrence of oral lesions in PR has been considered more frequent in dark-skinned patients compared to light-skinned patients. However, in 12 Caucasian adult patients with persistent PR that have been recently described, oral lesions were very common (75% of cases). Another study on the clinical features and virological parameters of 31 Caucasian children with PR showed that painless oropharyngeal lesions were present in 35% of them, a rate much higher than those reported in adult dark-skinned (9%) and Caucasian patients (16%) with typical PR.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180222
[Lr] Last revision date:180222
[St] Status:In-Process

  9 / 3184 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 29447634
[Au] Autor:Magro C; Guo R; Nguyen GH; Tsang H; Momtahen S
[Ad] Address:Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York. cym2003@med.cornell.edu.
[Ti] Title:Pityriasis lichenoides-like drug reaction: A clinical histopathologic study of 10 cases.
[So] Source:Dermatol Online J;23(11), 2017 Nov 15.
[Is] ISSN:1087-2108
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:BACKGROUND: Lymphomatoid drug reactions can mimic endogenous T and B cell lymphoproliferative diseases. OBJECTIVES: We present a novel form of cutaneous drug reaction with features of pityriasis lichenoides (PL), a recognized form of T cell dyscrasia. METHODS: Ten cases were studied where a cutaneous eruption exhibiting semblance to PL within a few weeks to months after starting a particular drug. RESULTS: The patient cohort comprised 7 females and 3 males with the mean age of 60 years. Widely distributederythematous cutaneous lesions were present in 6 cases whereas a more localized distribution was seen in three cases. The most frequently implicated drugsassociated with the eruption were antidepressants and statins. Histologic examination showed a morphologic picture identical to PL including marked epitheliotropism of mildly atypical lymphocytes, psoriasiform epidermal hyperplasia, dyskeratosis, hemorrhage, and a thick parakeratotic scale. Therewas a significant reduction in the expression of CD7 and CD62L amid the T cells. Regression of the eruption occurred in all cases excluding one. CONCLUSION: Thefindings conform the categorization of this process as a form of T-cell dyscrasia albeit one that is reversible, dependent on the drug withdrawal. The limitationof our study includes the retrospective design of the study.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180215
[Lr] Last revision date:180215
[St] Status:In-Process

  10 / 3184 MEDLINE  
              first record previous record
select
to print
Photocopy
Full text

[PMID]: 29440245
[Au] Autor:Kelly A; Lally A
[Ad] Address:Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland.
[Ti] Title:Pityriasis rubra pilaris: a rare inflammatory dermatosis.
[So] Source:BMJ Case Rep;2018, 2018 Feb 11.
[Is] ISSN:1757-790X
[Cp] Country of publication:England
[La] Language:eng
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180214
[Lr] Last revision date:180214
[St] Status:In-Data-Review


page 1 of 319 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information